| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/13/2009 | EP2056829A2 Using pi3k and mek modulators in treatments of cancer |
| 05/13/2009 | EP2056827A1 Method for inducing tumor apoptosis by increasing nitric oxide levels |
| 05/13/2009 | EP2056817A1 Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system |
| 05/13/2009 | EP2056812A1 Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases |
| 05/13/2009 | EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 05/13/2009 | EP2056801A1 Ruthenium ii compounds |
| 05/13/2009 | EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 05/13/2009 | EP1490490B1 Antisense iap nucleobase oligomers and uses thereof |
| 05/13/2009 | EP1478778B1 Method and nucleic acids for the analysis of a colon cell proliferactive disorder |
| 05/13/2009 | EP1473298B1 Supermolecular carboplatinum derivatives, their preparation and pharmaceutical composition containing them as active ingredient and applications of the compositions |
| 05/13/2009 | EP1466174B1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1305026B1 Barbituric acid analogs as therapeutic agents |
| 05/13/2009 | EP1299388B1 Variolin derivatives as anti-cancer agents |
| 05/13/2009 | EP1212405B1 Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 05/13/2009 | EP1062209B1 Metabolically inert anti-inflammatory and anti-tumor antifolates |
| 05/13/2009 | EP0914325B1 Modulators of the function of fas receptors and other proteins |
| 05/13/2009 | CN101432428A Recombinant human interferon-like proteins |
| 05/13/2009 | CN101432308A FAS binding antibodies |
| 05/13/2009 | CN101432307A Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 05/13/2009 | CN101432304A Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
| 05/13/2009 | CN101432303A Methods for damaging cells using effector functions of anti-CDH3 antibodies |
| 05/13/2009 | CN101432287A Pyrrolopyrimidine derivatives used as HSP90 inhibitors |
| 05/13/2009 | CN101432284A Dihydropyrazolopyrimidinone derivative |
| 05/13/2009 | CN101432281A 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
| 05/13/2009 | CN101432276A Quinoline derivatives |
| 05/13/2009 | CN101432022A Methods for damaging cells using effector functions of anti-epha4 antibodies |
| 05/13/2009 | CN101432021A Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 05/13/2009 | CN101432014A Cathepsin propeptide and uses thereof |
| 05/13/2009 | CN101432012A Pharmaceutical combination for the treatment and or chemosensibilization of refractory tumors to anticancer drugs |
| 05/13/2009 | CN101432005A Polymer-based anti-cancer agents |
| 05/13/2009 | CN101431993A Use of DHA and ARA in the preparation of a composition for regulating gene expression |
| 05/13/2009 | CN101429525A Antineoplastic invasion transfer function of snake venom metalloprotease inhibitors BJ46a and uses thereof |
| 05/13/2009 | CN101429523A Type T non--viral vector and composite medicament containing the same |
| 05/13/2009 | CN101429496A Culture medium for human peripheral blood source hemopoietic stem cell |
| 05/13/2009 | CN101429495A Cultivation method for human peripheral blood source hemopoietic stem cell |
| 05/13/2009 | CN101429251A Antineoplastic amalgamation protein, preparation method and uses thereof |
| 05/13/2009 | CN101429235A New high-efficiency low-toxicity actinomycin type D antineoplastic compound |
| 05/13/2009 | CN101429234A Vaccine based on simulating human blood vessel endothelial cell growth factor VEGF epitope and preparation method thereof |
| 05/13/2009 | CN101429218A Preparation of novel organic platinum complex and uses thereof |
| 05/13/2009 | CN101429216A Organic stibium complex, preparation and uses thereof |
| 05/13/2009 | CN101429201A Lemon acid berbamine salt, preparation method and application thereof |
| 05/13/2009 | CN101429198A Banisterine derivant and uses thereof |
| 05/13/2009 | CN101429190A 4,5-disubstitutedphenyl-3H-1,2-disulphur heterocycle pentene-3-thioketone, -ketone, -ketoxime derivants and uses thereof |
| 05/13/2009 | CN101429189A 2,3-disubstituted aryl thiophene derivants and uses thereof |
| 05/13/2009 | CN101429181A P-hydroxybenzene acrylic acid derivative and uses thereof |
| 05/13/2009 | CN101429175A Perilla alcohol derivant with antineoplastic activity and uses thereof |
| 05/13/2009 | CN101429174A Piperazine derivant with antineoplastic activity |
| 05/13/2009 | CN101429158A 2,4-diketone quinoline alkaloid, preparation and uses thereof |
| 05/13/2009 | CN101428148A RGD polypeptide radiopharmaceuticals and preparation method thereof |
| 05/13/2009 | CN101428147A Process for producing composite intravenous injection formulation for treating stomach cancer |
| 05/13/2009 | CN101428146A Process for producing composite injection formulation for treating esophagus cancer |
| 05/13/2009 | CN101428129A Effective component of turmeric rhizome, preparation method and uses thereof |
| 05/13/2009 | CN101428120A Effective component of phragmites communis trin, preparation method and use thereof |
| 05/13/2009 | CN101428089A Medicine for treating cancer |
| 05/13/2009 | CN101428083A Effective component of cortex dictamni, preparation method and use thereof |
| 05/13/2009 | CN101428071A Effective component of pulsatilla, preparation method and use thereof |
| 05/13/2009 | CN101428065A Effective component of nutgall, preparation method and use thereof |
| 05/13/2009 | CN101428064A Effective component of schisandra chinensis, preparation method and use thereof |
| 05/13/2009 | CN101428063A Effective component of schisandra chinensis, preparation method and use thereof |
| 05/13/2009 | CN101428062A Effective component of schisandra chinensis, preparation method and use thereof |
| 05/13/2009 | CN101428053A Cowherb seed effective component, preparation method and use thereof |
| 05/13/2009 | CN101428047A Process for producing pericarpium granati total phenols and uses thereof |
| 05/13/2009 | CN101428043A Effective component of chebula fruit, preparation method and use thereof |
| 05/13/2009 | CN101428039A Educated nk t cells and their uses in the treatment of immune-related disorders |
| 05/13/2009 | CN101428035A Gemcitabine hydrochloride or gemcitabine composition |
| 05/13/2009 | CN101428034A Antineoplastic combined medicament with enhancing and poison-reducing character |
| 05/13/2009 | CN101428033A Mix-configuration ginsenoside Rh2 and uses thereof |
| 05/13/2009 | CN101428029A Uses of curcurbitacin in producing medicament for treating cancer |
| 05/13/2009 | CN101428025A New use of anti-impaludism medicament hydroxyl chloroquine |
| 05/13/2009 | CN101428016A Uses of di-indole methyl hydride and its derivant in treating rheumatoid arthritis |
| 05/13/2009 | CN101428013A Uses of tanshinone IIA vein emulsion in treating brain diseases |
| 05/13/2009 | CN101428004A Green process for producing nano-hydrophilic fat medicament based on amphiphilic block polymer |
| 05/13/2009 | CN101428003A Preparation of RGDF-fatty alcohol couplet mediated adriablastina target lipid and uses as anti-tumour agents |
| 05/13/2009 | CN101428002A Paclitaxel freeze drying microemulsion for injection and method of producing the same |
| 05/13/2009 | CN101427998A Astragalus polysaccharide calcium phosphate nano-paclitaxel composite injection, preparation method and application thereof |
| 05/13/2009 | CN101427996A Novel anticancer sustained-release injection |
| 05/13/2009 | CN101427995A Anticancer sustained-release agent |
| 05/13/2009 | CN101427994A Gemcitabine-containing anti-cancer medicine sustained-release injection |
| 05/13/2009 | CN101427719A Instant anticancer tea of fig |
| 05/13/2009 | CN100487452C Quality control method of injection preparation used for treating tumour |
| 05/13/2009 | CN100487125C Recombinant adeno-associated virus comprising VEGFR Truncated Soluble cDNA and gene therapeutic agent comprising the same |
| 05/13/2009 | CN100487123C Method for coustructing shRNA expression carrier for inhibiting N-acetylglucosamine transferase V and its use |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/13/2009 | CN100486995C Compositions and methods for WT1 specific immunotherapy |
| 05/13/2009 | CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 05/13/2009 | CN100486991C Screening and authentication of polypeptide binding specificly to tumour tranferring cell |
| 05/13/2009 | CN100486988C Process for preparing 20(R)-ginsenoside Rh2 |
| 05/13/2009 | CN100486987C Antivira and antitumor deoxyoligonucleotide containing CpG single strand |
| 05/13/2009 | CN100486971C Compound 2,3,4,6,8-pentamethoxyl-dibenzofuran and its use |
| 05/13/2009 | CN100486969C Cis-2,4,5-triphenyl-imidazoline and its application in tumor treatment |
| 05/13/2009 | CN100486646C Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy |
| 05/13/2009 | CN100486645C Medicine composition containing cyclodextrin included taxol and its preparation process |
| 05/13/2009 | CN100486619C Combination of medication for treating tumorous diseases and preparation method |
| 05/13/2009 | CN100486605C Big bitter gourd in application for preparing medication |
| 05/13/2009 | CN100486596C Chinese medicine preparation with organism immunity increasing function |
| 05/13/2009 | CN100486595C Brazil mushroom soluble small molecular extract, its preparation technology and use |
| 05/13/2009 | CN100486587C Clarithromycin liposome microsphere injection and its preparation method |
| 05/13/2009 | CN100486585C Antitumor ginsenoside Rh2 injection and its preparation process |